Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine-Reference-Cited by-同舟云学术

Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine

Published:2023-03-04 Issue:3 Volume:19 Page:165-174
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Biswas Mohitosh¹²³^ORCID,Shobana John²³,Jinda Pimonpan²³^ORCID,Sukasem Chonlaphat²³⁴

Affiliation:

1. Department of Pharmacy, University of Rajshahi, Rajshahi, Bangladesh

2. Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

3. Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand

4. Pharmacogenomics and Precision Medicine, The Preventive Genomics & Family Check-up Services Center, Bumrungrad International Hospital, Bangkok, Thailand

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2203860

Reference85 articles.

1. Current and Emerging Azole Antifungal Agents

2. Voriconazole: A New Triazole Antifungal Agent

3. Posaconazole: A Broad-Spectrum Triazole Antifungal Agent

4. Oral Azole Drugs as Systemic Antifungal Therapy

5. In Vitro Activities of Approved and Investigational Antifungal Agents against 44 Clinical Isolates of Basidiomycetous Fungi

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi;Pharmacogenomics and Personalized Medicine;2024-05